What Researchers Did
Researchers at NASA conducted ground-based trials to study the risk of decompression sickness during simulated space walks.
What They Found
Out of 426 simulated altitude exposures, 17% of participants experienced symptoms of decompression sickness, and 42% had detectable microbubbles in their blood. About 27% of symptomatic exposures led to the test being stopped, with one-third of these requiring hyperbaric chamber treatment. The risk of symptoms was 3.20 times higher when microbubbles were present and 4.3 times higher with an increasing number of exposures.
What This Means for Canadian Patients
This study provides insights into the risk factors for decompression sickness, a condition that can affect divers and those exposed to rapid changes in pressure. Understanding these risks can help in developing better prevention strategies and identifying individuals who may need hyperbaric oxygen therapy for treatment. For Canadian patients, this knowledge contributes to the broader understanding of DCS management, particularly for those involved in activities like diving or aviation.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. However, decompression sickness is a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
The study was conducted in a simulated environment using healthy subjects, which may not fully reflect real-world conditions or diverse patient populations.